CARLSBAD, CA--(Marketwire - April 28, 2009) -
Applied Nanoscience Inc. (ANI) (PINKSHEETS:
APNN), a nanotechnology-based filtration development company, today
commented that the unusually heavy share volume and active trading in its
stock yesterday is likely tied to the current swine flu outbreak. More
specifically, the potential applicability of the company's core technology,
NanoFense™, a proprietary antimicrobial nanoparticle formulation developed
by ANI to coat or impregnate virtually any air filter media could be viewed
as an advantageous product enhancement by air filtration companies.
ANI's NanoFense formulation has already been validated at well-known BSL-3
laboratories to be highly effective against the avian influenza simulant
strain H9N2, the Human Influenza A virus as well as Haemophilus influenzae
(H-flu). According to an independent virologist familiar with the
technology and past testing, it is highly probable that the NanoFense
formulation will be similarly effective against the current swine influenza
strain A/H1N1.
About ANI
ANI is a marketer and developer of innovative, high performance
nanotechnology-based filtration products to customers worldwide and is the
owner of NEFT™ (Nanoparticle - Enhanced - Filtration - Technology), a
broad platform with significant application potential in consumer market
segments.
For further information about Applied Nanoscience Inc., please visit:
www.appliednanoscience.com
Safe Harbor Statement
This release may contain statements that are forward-looking. Such
statements are made based upon current expectations that are subject to
risk and uncertainty. ANI does not undertake to update forward-looking
statements in this news release to reflect actual results of and changes in
assumptions or changes in other factors affecting such forward-looking
information. The actual future plans and results of the company could
differ significantly from such forward-looking statements.
